Hedge Fund and Insider Trading News: Kyle Bass, Ray Dalio, Fortress Investment Group, CVS Health Corp (CVS), and More

Kyle Bass Says He Foresees ‘Severe’ Hong Kong Economic Decline (Bloomberg)
Kyle Bass, founder of Hayman Capital Management, said Hong Kong faces a “severe” economic decline as anti-government protests escalate. The Dallas-based hedge fund manager, who is betting that Hong Kong’s currency peg will break, said the former British colony’s economy is being drained of liquidity. Hong Kong’s foreign exchange reserves will worsen for September and October and a significant amount of capital and investment will leave in next 12 months to 18 months, he told a conference in Amsterdam on Wednesday.

Fortress Extends Offer on Japan’s Unizo After Being Jilted as White Knight (Reuters)
TOKYO (Reuters) – SoftBank-backed (3248.T) Fortress Investment Group said on Wednesday it had extended its tender offer for Unizo Holdings (3248.T) for a second time, after the Japanese hotel chain abruptly withdrew its support for a $1.3 billion buyout bid. Fortress’s bid, originally a “white knight” offer, was thrown into doubt last week with Unizo saying Fortress had not met its demands for a higher offer price or its concerns about employment of current staff. Unizo’s about-face has complicated Fortress’ bid and raised the possibility that the investment group could turn into a hostile bidder. It also marks the latest twist in a fractious deal that began with a separate hostile bid by H.I.S. Co (9603.T) and has drawn in U.S. hedge fund Elliott Management, which now owns around a 10% stake in Unizo.

Countries with the Smallest Government Per Capita in the World

Pressmaster/Shutterstock.com

Ray Dalio Warns the White House’s Latest Plan to Clamp Down on Chinese Investment Could Soon Become a Reality. Here’s Why He Thinks ‘All Market Participants Need to Worry.’ (Business Insider)
Ray Dalio, the founder and cochief investment officer of Bridgewater Associates – the world’s largest hedge fund – expresses his worry over the Trump administration’s new plan to curb US investment in China. The hedge fund mogul likens this latest development to a period between 1935 and 1945 where a similar scenario resulted in the use of emergency powers and then, eventually, disaster. Dalio thinks that all market participants need to be concerned if today’s advancements follow a similar path.

Bill Ackman Has His Revenge On Montezuma’s Revenge (Deal Breaker)
The end of last week was a tough time for Bill Ackman. For the second time, a federal regulator said he was right about Herbalife, the diet-shake purveyor Ackman spent years calling the biggest pyramid-shaped fraud around. And for the second time, that regulator chose to issue a slap on the wrist rather than shut the place down, meaning its shares have gone down to $37.70, but not to zero, as Ackman promised. Of course, that’s all pretty meaningless to Ackman now, since he abandoned his quest a year-and-a-half ago at a loss of $1 billion, but it must have been pretty galling all the same. Luckily, this being the Ackmanaissance, he had consolations to turn to.

New Hedge Fund Solel Partners Starts Trading With $600 Million (Bloomberg)
Solel Partners, the hedge fund started by former Highfields Capital Management partners, began trading this week with $600 million, according to a person familiar with the matter. Money managers Craig Peskin and Peter Fleiss count Highfields founder Jon Jacobson among their investors, as well as foundations, endowments and other high-net-worth individuals, said the person, who asked not to be identified because the matter is private. The value-oriented credit and equity fund started trading Tuesday from Boston.

BMS: Divestiture, Addition, and Performance (Hedge Nordic)
Stockholm (HedgeNordic) – Brummer Multi-Strategy, a multi-strategy fund investing in single-strategy hedge funds within the Brummer & Partners family, gained 4.1 percent year-to-date through the end of September. The fund of funds had to give up some gains in September, as trend-following CTAs were hit by a rebound in bond yields and long/short equity strategies struggled due to massive sector rotations. In a recent interview, Mikael Spångberg, one of the portfolio managers responsible for Brummer Multi-Strategy, discussed the fund’s year-to-date and September performance, touched upon the decision to divest Nektar and briefly discussed a new addition to the fund.

Private Capital Performance Update: Q4 2018 (Preqin.com)
This report provides the latest private capital performance data from Preqin Pro to Q4 2018, including horizon IRRs, assets under management, median net IRRs and PME benchmarking. Plus, league tables for the most consistent top performing fund managers across strategies.

Cvs Health Corp (CVS) EVP, ENT STRATEGY & DIGITAL Joshua Matthew Flum Sold $1.1 million of Shares (Guru Focus)
EVP, ENT STRATEGY & DIGITAL of CVS Health Corp., Joshua Matthew Flum, sold 17,703 shares of CVS on 09/30/2019 at an average price of $63 a share. The total sale was $1.1 million. CVS Health Corp operates in the healthcare sector. Its primary business is that of operating retail pharmacies. The company has three reportable segments namely Pharmacy Services, Retail/LTC, and Corporate. CVS Health Corp has a market cap of $81.09 billion; its shares were traded at around $62.35 with a P/E ratio of 17.48 and P/S ratio of 0.33.

SEC Charges Northbrook Hedge Fund Execs with Fraud (MooseGazette.net)
Two executives at a Northbrook hedge fund have been billed with fraud after allegedly dishonest shoppers out of more than a million pounds. Samuel Barnett and Matthew Aven, top rated executives at SBB Investigate Team, LLC, made use of their possess valuation design to inflate the price of their investments, the Securities and Exchange Commission mentioned. The pair used that product to misstate the fund’s historical performance and overcharged investors about $1.4 million in charges, the SEC mentioned.

SEC Obtains Final Judgment Against Investment Banker Charged in Insider Trading Scheme (STL.News.com)
(STL.News) – On September 30, 2019, a federal court judge entered a final judgment in the SEC’s action against Woojae (“Steve”) Jung, a former employee of a prominent investment bank charged with repeatedly using his access to highly confidential information in order to place illicit and profitable trades in advance of deals on which the bank was providing investment banking services. The SEC filed its action in May 2018 and Jung was also charged criminally by the U.S. Attorney’s Office for the Southern District of New York. In the parallel criminal case, Jung pled guilty to securities fraud and was sentenced to a term of incarceration of 3 months, forfeiture to the United States in the amount of $130,000, a $30,000 fine, and 2 years of supervised release.

Aurobindo Co-Founder Hit With $3m Fine For Insider Trading (Pharma Intelligence Informa)
Indian stock market regulator SEBI has slapped the billionaire founder of Aurobindo Pharma, along with other promoters of the company, with a more than $3m fine for allegedly violating insider trading norms over a string of licensing agreements with multinational Pfizer.

CFTC Orders Six Financial Institutions to Pay Total of More Than $6 Million for Reporting Failures (HedgeCo.net)
(HedgeCo.Net) The U.S. Commodity Futures Trading Commission today announced that it issued orders yesterday against HSBC Bank USA, N.A., Société Générale International Limited, The Northern Trust Company, NatWest Markets Plc, The Bank of New York Mellon, and PNC Bank, National Association for reporting failures. Société Générale International Limited and The Northern Trust Company were also charged with failing to supervise in connection with the reporting failures. HSBC was also charged with violating swap-dealer risk management regulations, the first time the Commission has brought such an action. “Accurate reporting is essential to effective fulfillment of the regulatory functions of the CFTC, including meaningful surveillance and enforcement programs,” said CFTC Director of Enforcement James McDonald. “As these actions show, the CFTC will continue to vigorously enforce reporting requirements. The CFTC will also take appropriate action where reporting failures are occurring as a result of serious supervisory failures.”

Daily Insider Ratings Round Up 9/30/19 (Seeking Alpha)
On Today’s Tables: Insider trades were rated Significant at: Ulta Beauty (ULTA); Occidental Petroleum (OXY), and; Anterix (ATEX). Insider trades were rated Nearly Significant at: Provention Bio (PRVB), and; FlexShopper (FPAY).